Optimizing Dosage in Pharmacotherapy-Missing the Forest for the Trees

Affiliations

¹ Health Data Synthesis Institute, Kansas City, Missouri, USA.
² Kansas City University-Joplin, Joplin, Missouri, USA.
³ Momentum Metrix, Leawood, Kansas, USA.
⁴ Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

Susan M Abdel-Rahman et al. Clin Pharmacol Ther. 2024 Sep.

. 2024 Sep;116(3):511-514.

doi: 10.1002/cpt.3268. Epub 2024 Apr 15.

¹ Health Data Synthesis Institute, Kansas City, Missouri, USA.
² Kansas City University-Joplin, Joplin, Missouri, USA.
³ Momentum Metrix, Leawood, Kansas, USA.
⁴ Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

No abstract available

References

1. Patel, M. & Raphael, J.L. Pediatric subspecialty pipeline: aligning care needs with a changing pediatric health care delivery environment. Pediatr. Res. 93, 1791–1793 (2023).
1. Roehrig, C. Mental disorders top the list of the Most costly conditions in the United States: $201 billion. Health Aff. 35, 1130–1135 (2016).
1. Lester, H., Tritter, J.Q. & Sorohan, H. Patients' and health professionals' views on primary care for people with serious mental illness: focus group study. BMJ 330, 1122 (2005).
1. Campbell, S.M., Gately, C. & Gask, L. Identifying the patient perspective of the quality of mental healthcare for common chronic problems: a qualitative study. Chronic Illn. 3, 46–65 (2007).
1. Basyouni, D. & Shatnawi, A. Pharmacogenomics instruction depth, extent, and perception in US medical curricula. J. Med. Educat. Curri. Develop. 7, 2382120520930772 (2020).